Bharat Biotech's COVID-19 shot safe, produced immune response in early human trial - The Lancet
Indian drugmaker Bharat Biotech's coronavirus vaccine, which has been authorized for use in the country, proved safe and produced an immune response in a small group of adults aged 18 to 55, according to a study published in The Lancet medical journal.